期刊文献+

氯诺昔康醇质体凝胶剂的制备及其体外经皮渗透研究 被引量:5

Study on Preparation and Transdermal Permeation of Lornoxicam Ethosomal Gel in Vitro
原文传递
导出
摘要 目的制备氯诺昔康(LN)醇质体凝胶剂,并考察其体外经皮渗透特性。方法采用乙醇注入法制备氯诺昔康醇质体,以包封率为指标,利用正交设计优化处方和制备工艺,并对醇质体形态、粒径、Zeta电位及包封率进行评价,并以卡波姆为基质制备醇质体凝胶;采用Franz扩散池和小鼠皮肤进行体外经皮渗透实验,以HPLC测定药物浓度并计算药物累积渗透量、稳态透皮速率和皮内滞留量。结果氯诺昔康醇质体外形圆整,平均粒径为(385.6±59.2)nm,Zeta电位为(-23.49±2.38)mV,平均包封率为(73.44±1.35)%。制得的醇质体凝胶剂为黄色半透明黏稠状胶体,稳态透皮速率J为(2.81±0.68)μg·cm-2·h-1,是其水混悬液的12.77倍,是普通凝胶的3.51倍,是体积分数30%乙醇水混悬液的2.60倍,24 h时氯诺昔康在皮肤中的滞留量排序为醇质体凝胶>普通凝胶>体积分数30%乙醇水混悬液>水混悬液。结论氯诺昔康醇质体凝胶制备工艺简便可行,质量稳定可控,可显著提高药物的透皮速率,增加药物在皮肤中的滞留量。 OBJECTIVE To prepare lornoxicam (LN) ethosomal gel and to study its transdermal permeation in vitro. METH- ODS The LN ethosomes were prepared by ethanol injection method. The formulation and the preparation method of ethosomes were optimized by orthogonal experiment using encapsulation efficiency as index. The morphology, particle size, Zeta potential and entrap- ment efficiency were evaluated, and the carbomer was added as the base for the preparation of the ethosomal gel. The penetration ex- periments of LN ethosomal gel through mouse skin were performed by Franz' s cell. The concentration of LN was determined by HPLC. The cumulative penetration amount, steady penetration rate and the skin deposition of the drug were calculated. RESULTS The ob- tained ethosomes were spherical, the mean size and Zeta potential were (385.6 ±59.2) nm and ( - 23.49 ±2. 38) mV, respective- ly. The mean entrapment efficiency of LN in ethosomes was (73.44 ± 1.35) %. The LN ethosomal gel had a translucent yellow viscous colloidal appearance. The steady penetration rate of LN from ethosomal gel (2. 81μg·cm^-2·h^-1) was 12.77, 3.51 and 2. 60 times higher than that from suspensions, gel and hydroethanolic suspensions of LN, respectively. The skin deposition of the drug at the end of the experiment was statistically greater from the ethosomal gel than from other control groups. CONCLUSION The gel is feasible in preparation technique, stable and controllable in quality and can improve transdermal penetration and increased the LN amount retain in the skin significantly.
出处 《中国药学杂志》 CAS CSCD 北大核心 2014年第4期309-315,共7页 Chinese Pharmaceutical Journal
基金 烟台市科技发展计划项目(2010326)
关键词 氯诺昔康 醇质体凝胶 正交设计 经皮渗透 lornoxicam ethosomal gel orthogonal design cutaneous permeation
  • 相关文献

参考文献15

  • 1JULIA A, BALFOUR A F, BARRADELL L B. Lornoxicam. A review of its pharmacology and therapeutic potential in the man- agement of painful and inflammatory conditions [ J ]. Drugs, 1996,51 (4) .639-657.
  • 2MEINEKE I,TURCK D. Population pharmacokinetic analysis of meloxicam in rheumatoid arthritis patients [ J ]. Br J Clin Phar- macol,2003,55 ( 1 ) .32-38.
  • 3YAKHNO N, GUEKHT A,SKOROMETS A,et al. Analgesic effi- eacy and Mety of lornoxicam quick-release formulation compared with diciofenac potassium. Randomised, double-blind trial in a- cute low basek pain[ J]. Clin Drug Investig,2006,26(5 ) . 267- 277.
  • 4SINGLA K, RAO R, SAINI V. Preparation and evaluation of lor- noxicam niosonml gel [ J ]. Int Res J Pharm, 2012,3 ( 4 ) . 378- 383.
  • 5GULGUN Y,UNER M,GONDLLU U. Design of meloxieam and lornoxicam transdermal patches. Preparation, physical character- ization, ex vivo and in vivo studies [ J ]. Chem Pharm Bull,2010, 58(11) . 1466-1473.
  • 6TOUITOU E, DAYAN N, BERGELSON L,et al. Ethosomes-novel vesicular carriers for enhanced delivery. Characterization and skin penetration properties [ J ]. J Controlled Release, 2000,65 . 403-418.
  • 7杨羽行,刘小平.美洛昔康醇质体凝胶的研制[J].中国医药导报,2011,8(35):78-80. 被引量:8
  • 8李珂珂,吕青志,赵娟娟,张晓帆,关景欣.HPLC法测定人血浆中氯诺昔康浓度[J].中国药师,2012,15(11):1565-1567. 被引量:2
  • 9郭咸希,何杨虎,何文,肖礼海,李勇,何平平.尼美舒利脂质体凝胶的研制及体外经皮渗透动力学考察[J].中国药学杂志,2008,43(1):35-39. 被引量:18
  • 10LIU L P, MAO Q,AN Y C. Study on in vitro percutaneous per- meabilities and antibacterial activities of clotrimazole-encapsula- ted ethosomes and liposomes[ J].中困药学杂志,2009,44(4).278-282.

二级参考文献21

共引文献27

同被引文献100

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部